Synthetic biology used to target cancer cells while sparing healthy tissue
Stanford researchers have developed synthetic proteins that can rewire cancer cells in a lab dish by co-opting critical disease-associated pathways.
Continue Reading
Stanford researchers have developed synthetic proteins that can rewire cancer cells in a lab dish by co-opting critical disease-associated pathways.
Continue Reading
Join the Discussion